NCT00985400

Brief Summary

The goal of this study is to compare the effects of exercise with the effects of relaxation training on physical function (how well participants perform normal daily activities) and symptoms related to your cancer diagnosis (such as tiredness, pain, and nausea).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
154

participants targeted

Target at P25-P50 for not_applicable colorectal-cancer

Timeline
Completed

Started Nov 2010

Longer than P75 for not_applicable colorectal-cancer

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 25, 2009

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 28, 2009

Completed
1.1 years until next milestone

Study Start

First participant enrolled

November 5, 2010

Completed
12.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2023

Completed
Last Updated

March 31, 2022

Status Verified

March 1, 2022

Enrollment Period

12.4 years

First QC Date

September 25, 2009

Last Update Submit

March 29, 2022

Conditions

Keywords

recurrent colon cancerstage IV colon cancerGastrointestinalExerciseRelaxationMeditation

Outcome Measures

Primary Outcomes (5)

  • Recruitment rate

    3 year study period

  • Patient retention

    3 year study period

  • Program and assessment implementation

    3 year study period

  • Patient adherence to behavioral recommendations

    Up to 20 weeks

  • Effect size of the exercise intervention on physical function

    Up to 20 weeks

Secondary Outcomes (1)

  • Effect size of the exercise intervention on symptoms and quality of life

    Up to 20 weeks

Study Arms (2)

Exercise Program

EXPERIMENTAL

Arm I (exercise program): Oncologist advice; Resistance bands \& pedometer with written/DVD instructions for resistance exercise twice a week for 16 weeks. Brief moderate-intensity walks multiple times a day for a total of 30 minutes increasing steps weekly by 10% to reach a minimum of 10,000 steps a day. Monthly newsletters; Telephone counseling weekly for 4 weeks then monthly for 12 weeks; and tailored message telephone prompts once every 2 weeks during last 12 weeks of the study intervention.

Behavioral: Exercise ProgramBehavioral: Telephone-based interventionOther: Counseling interventionOther: Questionnaire administration

Relaxation Intervention

EXPERIMENTAL

Arm II (relaxation program): Oncologist advice; Written/CD audio instructions on diaphragmatic breathing and guided imagery. Practice relaxation techniques for 15 minutes/day, 5-7 days/week, for 16 weeks. Monthly newsletters, telephone counseling, and tailored-message telephone prompts as in arm I.

Behavioral: Telephone-based interventionOther: Counseling interventionOther: Questionnaire administrationBehavioral: Relaxation Program

Interventions

Resistance exercising using resistance bands 2 days per week, and brief moderate-intensity walks multiple times a day for a total of 30 minutes increasing steps weekly by 10% to reach a minimum of 10,000 steps a day

Exercise Program

Patients will receive encouragement and social support from a telephone counselor once a week for the first 4 weeks and then once a month for the remaining 12 weeks.

Exercise ProgramRelaxation Intervention

Patients will receive advice from their doctor (in person), physician assistant, or other midlevel provider about exercising. They will also be given this advice in a letter.

Exercise ProgramRelaxation Intervention
Also known as: Survey
Exercise ProgramRelaxation Intervention

Relaxation techniques (breathing and meditation) provided at least 15 minutes per day for 5-7 days per week.

Relaxation Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of stage IV or recurrent colorectal cancer
  • Age \>/= 18 years
  • ECOG performance status of 0 -1
  • Able to communicate in English or Spanish
  • Able to give informed consent
  • Adequate organ function -Total bilirubin \< 1.5 x the institutional upper-normal limits (IUNL); AST (SGOT) and/or ALT (SGPT) \< 2.5 x IUNL; Patients with liver metastasis AST/ (SGOT) and/or ALT (SGPT) \< 5 x IUNL
  • Adequate bone marrow function: - Absolute neutrophil count \> 1,000/microLiters; Platelets \> 50,000/microLiters
  • Able to ambulate without assistance
  • Has access to a telephone in order to receive pre-recorded telephone messages and for multiple counseling sessions.

You may not qualify if:

  • Major surgery in the past 8 weeks
  • Medical contraindications to home-based exercise as defined by the treating physician
  • Symptomatic Bone Metastases
  • Unstable Angina (current symptomatic angina at time of enrollment)
  • Class III/IV heart failure according to NYHA classification system
  • Pulmonary conditions that require oxygen
  • Unable to ambulate without assistance (cane, walker, etc)
  • Exercising at a moderate-vigorous intensity for 150 minutes or more per week, exercising at a vigorous intensity for more than 20 minutes on 3 or more days per week, or performing resistance exercises for more than 20 minutes per day on two or more days per week for 3 months or more.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Texas MD Anderson Cancer Center

Houston, Texas, 77030-4009, United States

Location

Related Links

MeSH Terms

Conditions

Colorectal NeoplasmsColonic NeoplasmsMotor Activity

Interventions

Resistance TrainingCounselingSurveys and QuestionnairesRelaxation Therapy

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal DiseasesBehavior

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaMental Health ServicesBehavioral Disciplines and ActivitiesCommunity Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesData CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public HealthMind-Body TherapiesComplementary TherapiesBehavior TherapyPsychotherapy

Study Officials

  • Karen Basen-Engquist, PhD

    M.D. Anderson Cancer Center

    STUDY CHAIR
  • Michael J. Fisch, MD, MPH, FACP

    M.D. Anderson Cancer Center

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 25, 2009

First Posted

September 28, 2009

Study Start

November 5, 2010

Primary Completion

March 31, 2023

Study Completion

March 31, 2023

Last Updated

March 31, 2022

Record last verified: 2022-03

Locations